549 results on '"Lund, Lars H."'
Search Results
2. Generalizable Approach to Quantifying Guideline-Directed Medical Therapy
3. Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for Mortality Risk in Heart Failure
4. Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction – a secondary analysis of TOPCAT
5. Does Heterogeneity Exist in Treatment Associations With Renin–Angiotensin–System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?
6. Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic
7. Heart failure registries – Future directions
8. Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure
9. Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
10. Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF Registry
11. Changing health related quality of life and outcomes in heart failure by age, sex and subtype
12. Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF
13. Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction
14. Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3
15. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF
16. Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat
17. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
18. Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation
19. Identifying subtypes of heart failure from three electronic health record sources with machine learning: an external, prognostic, and genetic validation study
20. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
21. Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction
22. A machine learning model for prediction of 30-day primary graft failure after heart transplantation
23. Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF)
24. Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry
25. Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry
26. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
27. The management of heart failure in Sweden—the physician’s perspective: a survey
28. More Evidence That HF With Normal EF Is Distinct From HF Below Normal EF
29. Cause‐specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure Registry
30. From mid-range to mildly reduced ejection fraction heart failure: A call to treat
31. Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat
32. Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population
33. Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry
34. Heart failure with mid-range or mildly reduced ejection fraction
35. The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT‐HFpEF): Rationale and design.
36. Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry.
37. Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis.
38. Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.
39. Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner
40. The Longest Living Patient Supported With Left Ventricular Assist Device (14 Years)
41. Inflammation and myeloperoxidase – The next treatment targets in heart failure?
42. Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry
43. Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic database
44. Abstract 11412: Use of Guideline-Directed Medical Therapies After Hospitalization for Heart Failure: Real-World Insights From EVOLUTION HF
45. Abstract 9620: External Validation of Deep Learning-Based Echocardiography Algorithms to Automate View Selection and Annotation of the Echocardiogram
46. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT
47. Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries
48. Insights into RC time curve fit analysis of pulmonary artery pressure decay.
49. Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry.
50. N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure events.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.